The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Benitec Biopharma Inc shares valued at $19,999,994 were purchased by SUVRETTA CAPITAL MANAGEMENT, L on Nov 07 ’25. At $13.50 per share, SUVRETTA CAPITAL MANAGEMENT, L acquired 1,481,481 shares. The insider’s holdings grew to 9,538,175 shares worth approximately $124.19 million following the completion of this transaction.
Also, SUVRETTA CAPITAL MANAGEMENT, L purchased 16,497 shares, netting a total of over 211,736 in proceeds. Following the buying of shares at $12.83 each, the insider now holds 8,807,805 shares.
Before that, SUVRETTA CAPITAL MANAGEMENT, L had added 900,000 shares to its account. In a trade valued at $11,700,000, the Director bought Benitec Biopharma Inc shares for $13.00 each. Upon closing the transaction, the insider’s holdings increased to 900,000 shares, worth approximately $114.49 million.
As published in their initiating research note from TD Cowen on July 07, 2025, Benitec Biopharma Inc [BNTC] has been a Buy. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. As of December 13, 2024, Robert W. Baird has initiated its “an Outperform” rating for BNTC. Earlier on October 16, 2024, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for BNTC stock.
Analyzing BNTC Stock Performance
On last trading session, Benitec Biopharma Inc [NASDAQ: BNTC] rose 0.66% to $13.02. The stock’s lowest price that day was $12.65, but it reached a high of $13.09 in the same session. During the last five days, there has been a drop of approximately -0.65%. Over the course of the year, Benitec Biopharma Inc shares have jumped approximately 24.07%. Shares of the company reached a 52-week high of $17.15 on 06/10/25 and a 52-week low of $9.70 on 02/13/25.
Support And Resistance Levels for Benitec Biopharma Inc (BNTC)
According to the 24-hour chart, there is a support level at 12.75, which, if violated, would cause prices to drop to 12.48. In the upper region, resistance lies at 13.19. The next price resistance is at 13.36. RSI (Relative Strength Index) is 39.68 on the 14-day chart, showing neutral technical sentiment.
Is Benitec Biopharma Inc subject to short interest?
Stocks of Benitec Biopharma Inc saw a sharp rise in short interest on 2025-11-14 jumping by 0.29 million shares to 1.41 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 1.13 million shares. A jump of 20.21% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.92 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.92.
Which companies own the most shares of Benitec Biopharma Inc (BNTC)?
In terms of Benitec Biopharma Inc share price expectations, FactSet research, analysts set an average price target of 29 in the next 12 months, up nearly 124.28% from the previous closing price of $12.93. Analysts anticipate Benitec Biopharma Inc stock to reach 32 by 2025, with the lowest price target being 22. In spite of this, 1 analysts ranked Benitec Biopharma Inc stock as Buy at the end of 2025. On September 12, 2024, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $17.
